1. Home
  2. CDTX vs YSG Comparison

CDTX vs YSG Comparison

Compare CDTX & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • YSG
  • Stock Information
  • Founded
  • CDTX 2012
  • YSG 2016
  • Country
  • CDTX United States
  • YSG China
  • Employees
  • CDTX N/A
  • YSG N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • YSG Package Goods/Cosmetics
  • Sector
  • CDTX Health Care
  • YSG Consumer Discretionary
  • Exchange
  • CDTX Nasdaq
  • YSG Nasdaq
  • Market Cap
  • CDTX 980.1M
  • YSG 889.0M
  • IPO Year
  • CDTX 2015
  • YSG 2020
  • Fundamental
  • Price
  • CDTX $63.31
  • YSG $8.90
  • Analyst Decision
  • CDTX Strong Buy
  • YSG
  • Analyst Count
  • CDTX 11
  • YSG 0
  • Target Price
  • CDTX $52.11
  • YSG N/A
  • AVG Volume (30 Days)
  • CDTX 659.9K
  • YSG 562.1K
  • Earning Date
  • CDTX 08-07-2025
  • YSG 08-19-2025
  • Dividend Yield
  • CDTX N/A
  • YSG N/A
  • EPS Growth
  • CDTX N/A
  • YSG N/A
  • EPS
  • CDTX N/A
  • YSG N/A
  • Revenue
  • CDTX $302,000.00
  • YSG $475,930,821.00
  • Revenue This Year
  • CDTX N/A
  • YSG $17.93
  • Revenue Next Year
  • CDTX N/A
  • YSG $12.79
  • P/E Ratio
  • CDTX N/A
  • YSG N/A
  • Revenue Growth
  • CDTX N/A
  • YSG 0.90
  • 52 Week Low
  • CDTX $10.14
  • YSG $3.01
  • 52 Week High
  • CDTX $66.95
  • YSG $11.57
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 70.66
  • YSG 47.72
  • Support Level
  • CDTX $60.71
  • YSG $8.03
  • Resistance Level
  • CDTX $66.95
  • YSG $9.09
  • Average True Range (ATR)
  • CDTX 4.25
  • YSG 0.68
  • MACD
  • CDTX -0.39
  • YSG -0.21
  • Stochastic Oscillator
  • CDTX 79.25
  • YSG 28.90

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

Share on Social Networks: